J. Chennebault

发表

Immunoglobulins for treatment of systemic capillary leak syndrome.

P. Abgueguen, J. Chennebault, E. Pichard, 2010, The American journal of medicine.

Mycobacterium malmoense: an underestimated nontuberculous mycobacterium.

P. Abgueguen, J. Chennebault, E. Pichard, 2010, Diagnostic microbiology and infectious disease.

A case of sulphasalazine-induced DRESS syndrome with delayed acute interstitial nephritis.

J. Subra, J. Sayegh, J. Augusto, 2009, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

Nine Cases of Foodborne Botulism Type B in France and Literature Review

J. Granry, S. Fanello, P. Abgueguen, 2003, European Journal of Clinical Microbiology and Infectious Diseases.

Phase II Trial of Lenalidomide in HIV-Infected Patients with Previously Treated Kaposi's Sarcoma: Results of the ANRS 154 Lenakap Trial.

A. Desnoyer, D. Costagliola, C. Lebbé, 2016, AIDS research and human retroviruses.

Vascular thrombosis and acute cytomegalovirus infection in immunocompetent patients: report of 2 cases and literature review.

C. Payan, P. Abgueguen, J. Chennebault, 2003, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Acute cytomegalovirus infection and venous thrombosis: role of antiphospholipid antibodies.

S. Fanello, P. Abgueguen, J. Chennebault, 2007, The Journal of infection.

[Use of intravenous adrenalin in severe acute asthma].

P. Bourrier, J. Chennebault, P. Harry, 1992, Revue des maladies respiratoires.

First report of transmission of a highly resistant strain of HIV-1 group O.

L. Meyer, J. Plantier, T. Mourez, 2016, AIDS.

Impact of early cART on HIV blood and semen compartments at the time of primary infection

C. Rouzioux, J. Heitzmann, M. Müller-Trutwin, 2017, PloS one.

First report of Cryptococcus albidus septicaemia in an HIV patient.

E. Guého, J. Bouchara, D. Chabasse, 1996, The Journal of infection.

Use of infliximab to treat psoriatic arthritis in HIV-positive patients.

M. Audran, F. Berenbaum, K. Lacombe, 2007, Joint, bone, spine : revue du rhumatisme.

[Streptococcal toxic shock syndrome].

J. Alouf, P. Bourrier, H. Knöll, 1989, Presse medicale.

Sustained disappearance of hepatitis C viremia in patients receiving protease inhibitor treatment for human immunodeficiency virus infection.

F. Lunel, D. Vitour, C. Payan, 1999, The Journal of infectious diseases.

A highly virulent variant of HIV-1 circulating in the Netherlands

Michael J. Rausch, H. Jessen, A. Trkola, 2022, Science.

Immune restoration under HAART in patients chronically infected with HIV-1: diversity of T, B, and NK immune responses.

F. Lunel, B. Vielle, G. Rénier, 2006, Viral immunology.

[Pustular candidiasis in heroin addicts].

J. Chennebault, C. Leclech, J. Verret, 1997, Annales de dermatologie et de venereologie.

Severe lactic acidosis induced by nucleoside analogues in an HIV-infected man.

P. Roy, J. Chennebault, J. Gouello, 1999, Annals of emergency medicine.

Severe Lactic Acidosis Induced by Nucleoside

P. Roy, J. Chennebault, J. Gouello, 1999 .

Clinical aspects and prognostic factors of leptospirosis in adults. Retrospective study in France.

J. Cottin, S. Fanello, P. Abgueguen, 2008, The Journal of infection.

FSGS permeability factor-associated nephrotic syndrome : remission after oral galactose therapy

J. Subra, J. Sayegh, J. Augusto, 2009 .

A case report of Mycoplasma hominis brain abscess identified by MALDI-TOF mass spectrometry.

M. Kempf, C. Lemarié, M. Eveillard, 2014, International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases.

False-negative Results of Human Immunodeficiency Virus (HIV) Rapid Testing in HIV Controllers.

É. Oksenhendler, C. Katlama, D. Neau, 2019, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Efficacy and safety of stavudine and didanosine combination therapy in antiretroviral‐experienced patients

F. Raffi, C. Michelet, S. Billaudel, 1998, AIDS.

[Toxic myopathy due to hypolipemic agents].

P. Bourrier, J. Subra, J. Chennebault, 1990, Therapie.

Intoxication à l'iodoforme : 3 observations

A. Cailleux, P. Allain, J. Chennebault, 1992 .

[Breast abscess with Salmonella typhi and review of the literature].

S. Fanello, P. Abgueguen, J. Chennebault, 2007, Journal de gynecologie, obstetrique et biologie de la reproduction.

Human Immunodeficiency Virus Type 1 Group O Infection in France: Clinical Features and Immunovirological Response to Antiretrovirals

C. Charpentier, C. Delaugerre, J. Pawlotsky, 2018, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[Fatal poisoning by acebutolol].

A. Turcant, P. Allain, J. Chennebault, 1986, Therapie.

[Echocardiographic abnormalities in the stage IV of HIV infection].

J. Chennebault, J. Gouëllo, P. Tirot, 1993, Presse medicale.

Human cytomegalovirus DNA kinetics using a novel HCMV DNA quantitative assay in white blood cells of immunocompromised patients under Ganciclovir therapy.

N. Ifrah, F. Lunel, C. Ngohou, 1997, Journal of virological methods.

[Pyomyositis. Apropos of 5 cases].

M. Audran, A. Namour, C. Bregeon, 1993, Revue du rhumatisme.

Suspicion of fenofibrate-related drug reaction with eosinophilia and systemic symptoms (DRESS) syndrome: a case report.

J. Chennebault, L. Lagarce, Delphine Bourneau-Martin, 2014, Therapie.

Raltegravir-based regimens are effective in HIV-1 group O-infected patients.

J. Plantier, V. Daneluzzi, D. Batisse, 2012, Journal of acquired immune deficiency syndromes.

[Travelers' knowledge of vaccines. A survey including 400 people having consulted an international vaccination center].

S. Fanello, D. Chabasse, P. Abgueguen, 2009, Medecine et maladies infectieuses.

A traveler returning from South Africa with rash and genital ulceration.

P. Abgueguen, J. Chennebault, E. Pichard, 2004, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Decreased darunavir concentrations during once-daily co-administration with maraviroc and raltegravir: OPTIPRIM-ANRS 147 trial

C. Katlama, M. Shoai, H. Melliez, 2018, The Journal of antimicrobial chemotherapy.